AC Immune (ACIU) vs Pyxis Oncology, Inc. (PYXS)

AC Immune and Pyxis Oncology, Inc. are both Biotechnology companies. AC Immune and Pyxis Oncology, Inc. are of similar size ($250.2M and $249.4M). Pyxis Oncology, Inc. has the higher net margin (0.00% vs −1,783.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, AC Immune leads on 6 and Pyxis Oncology, Inc. on 5.

Valuation

Metric ACIU PYXS Biotechnology median
P/E n/m n/m 7.88
P/S 53.60 n/m 11.47
P/B 5.59 16.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 34.13 n/m 10.73
Earnings yield (32.54%) (49.30%) (28.84%)
Free cash flow yield (33.65%) (37.11%) (23.03%)

Profitability

Metric ACIU PYXS Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,745.75%) 0.00% 0.00%
Net margin (1,783.66%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (179.10%) (57.72%)
Return on assets 0.00% (99.62%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACIU PYXS Biotechnology median
Revenue growth (TTM) (85.56%) — 5.64%
EPS growth (last fiscal year) (44.83%) 3.03% —
Revenue growth, 5-year CAGR (47.84%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACIU PYXS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.93 1.34 4.73
Net debt to EBITDA 1.37 0.82 0.96

Dividend

Metric ACIU PYXS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACIU PYXS Biotechnology median
Market cap 249.35m 250.22m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack